KHTRF - Amneal Pharma inks licensing pact with Knight Therapeutics
2024-01-25 08:08:18 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals: By Most Measures, A Fundamentally Undervalued Company
- Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Amneal announces move to Nasdaq
- Amneal Pharma in pact with Strides to launch generic Vascepa